Xxera/openscience/retractions

Record #53981

Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer

Courtney J Riedinger, David A Barrington, Christa I Nagel, Wafa K Khadraoui, Paulina J Haight, Crystal Tubbs, Floor J Backes, David E Cohn, David M O'Malley, Larry J Copeland, Laura M Chambers

Journal

Gynecologic Oncology

Publisher

Original paper date

Mar 29, 2024

Original DOI

10.1016/j.ygyno.2024.03.020

Country

🇺🇸 United States

Institution

Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA · Gynecologic Oncology Section, Women's Services and The Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, USA · Department of Pharmacy, The Ohio State University Wexner Medical Center, USA

Open access

No

Article type

Research Article

Broad categories

(B/T) Business - Accounting (HSC) Medicine - Obstetrics/Gynecology (HSC) Medicine - Oncology (HSC) Medicine - Pharmacology

Citation lifecycle

How this paper is being cited

Pre-retraction

0

Same day

0

Post-retraction

3

% post-retraction

300.0%

~0.0 citations/yr before retraction · ~1.3 citations/yr after

— citing papers

Who is still citing this work

Loading…